Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
64,537,843
-
Shares change
-
+5,392
-
Total reported value, excl. options
-
$4,057,860,045
-
Value change
-
-$74,113,683
-
Put/Call ratio
-
1.68%
-
Number of buys
-
102
-
Number of sells
-
-103
-
Price
-
$62.85
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2021
255 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q4 2021.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,537,843 shares
of 1,091,129,524 outstanding shares and own 5.91% of the company stock.
Largest 10 shareholders include Invesco Ltd. (7,251,543 shares), BAILLIE GIFFORD & CO (5,138,846 shares), Capital World Investors (4,084,245 shares), BlackRock Inc. (3,692,456 shares), WELLINGTON MANAGEMENT GROUP LLP (3,548,115 shares), BRILLIANCE ASSET MANAGEMENT LTD (3,320,970 shares), FMR LLC (3,067,016 shares), VIKING GLOBAL INVESTORS LP (3,018,958 shares), CREDIT SUISSE AG/ (2,928,592 shares), and VANGUARD GROUP INC (2,200,303 shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.